Scancell Hldgs (UK) Today
SCLP Stock | 10.75 0.10 0.92% |
Performance0 of 100
| Odds Of DistressOver 85
|
Scancell Hldgs is selling for under 10.75 as of the 18th of December 2024; that is 0.92 percent decrease since the beginning of the trading day. The stock's lowest day price was 10.5. Scancell Hldgs has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Scancell Hldgs is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 929.6 M outstanding shares. More on Scancell Hldgs Plc
Moving against Scancell Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Scancell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Scancell Hldgs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Scancell Hldgs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO Director | Phil LHuillier | ||||
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Scancell Hldgs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Scancell Hldgs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsScancell Hldgs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Scancell Hldgs' financial leverage. It provides some insight into what part of Scancell Hldgs' total assets is financed by creditors.
|
Scancell Hldgs Plc (SCLP) is traded on London Exchange in UK and employs 61 people. Scancell Hldgs is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 103.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Scancell Hldgs's market, we take the total number of its shares issued and multiply it by Scancell Hldgs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Scancell Hldgs Plc operates under Biotechnology sector and is part of Health Care industry. The entity has 929.6 M outstanding shares.
Scancell Hldgs generates negative cash flow from operations
Check Scancell Hldgs Probability Of Bankruptcy
Ownership AllocationScancell Hldgs Plc shows a total of 929.6 Million outstanding shares. 30% of Scancell Hldgs Plc outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Scancell Ownership Details
Scancell Hldgs Plc Risk Profiles
Although Scancell Hldgs' alpha and beta are two of the key measurements used to evaluate Scancell Hldgs' performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 2.47 | |||
Standard Deviation | 3.79 | |||
Variance | 14.35 | |||
Risk Adjusted Performance | (0.1) |
Scancell Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Scancell Hldgs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Scancell Hldgs Corporate Management
Elected by the shareholders, the Scancell Hldgs' board of directors comprises two types of representatives: Scancell Hldgs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scancell. The board's role is to monitor Scancell Hldgs' management team and ensure that shareholders' interests are well served. Scancell Hldgs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scancell Hldgs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sathijeevan Nirmalananthan | Chief Officer | Profile | |
Mandeep Sehmi | Head Development | Profile | |
Fayaz Master | Head Operations | Profile | |
Sally Adams | Executive Officer | Profile | |
Adrian Parry | Head Manufacturing | Profile |
Additional Tools for Scancell Stock Analysis
When running Scancell Hldgs' price analysis, check to measure Scancell Hldgs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scancell Hldgs is operating at the current time. Most of Scancell Hldgs' value examination focuses on studying past and present price action to predict the probability of Scancell Hldgs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scancell Hldgs' price. Additionally, you may evaluate how the addition of Scancell Hldgs to your portfolios can decrease your overall portfolio volatility.